Recent ACON News
- Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain • GlobeNewswire Inc. • 04/25/2024 01:14:37 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/06/2024 09:09:09 PM
- Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Aclarion Announces Closing of $3.0 Million Public Offering • GlobeNewswire Inc. • 02/27/2024 08:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 07:00:20 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/27/2024 03:46:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/27/2024 05:15:34 AM
- Aclarion Announces Pricing of $3.0 Million Public Offering • GlobeNewswire Inc. • 02/26/2024 02:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/23/2024 04:46:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/21/2024 08:02:48 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 10:32:26 PM
- Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/01/2024 10:16:49 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/31/2024 10:26:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:04:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:53:59 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2024 09:48:49 PM
- Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD • GlobeNewswire Inc. • 01/22/2024 01:00:00 PM
- Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution • GlobeNewswire Inc. • 01/17/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/12/2024 09:15:59 PM
- Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/04/2024 01:01:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:00:11 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM